Clinical trial
Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
NCT00370032 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00370032 |
|---|---|
| Title | Study to Assess the Effect Of Alosetron On Mucosal Blood Flow |
| Official title | A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Irritable Colon |
| Intervention type | Drug |
| Interventions | alosetron |
| Enrollment | 49 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Aug 30, 2006 |
| Last update posted | May 18, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: